Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 754 evidences · page 6 / 71

47 %Globally, 47% of women and 38% of men with hypertension were treated in 2019.

Camerounhypertension artérielleobservé 2019publié 2021Lancet (London, England)europe_pmcdocument de 8 observations

14 %Among patients with type 1 diabetes (T1D), 14.0% reported having self-discontinued insulin.

Cameroundiabète de type 1observé 2016-2017publié 2021Advances in therapyeurope_pmcdocument de 12 observations

62,5 %62.5% of participants had a high cardiovascular risk score.

Camerounmaladies cardiovasculairespublié 2021Cureuseurope_pmcdocument de 9 observations

57,9 per_100000The death rate from injuries was 57.9 deaths per 100,000 in 2017.

Camerouninjuriesobservé 2017publié 2018Lancet (London, England)europe_pmcdocument de 15 observations

89 %The prevalence of the 20I/R substitution in protease sequences was 89% (51/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

50 %Wasting of shoulder girdle muscles was present in 50% of Cameroonian Duchenne Muscular Dystrophy patients (6 out of 12).

CamerounDuchenne Muscular Dystrophypublié 2020Molecular genetics & genomic medicineeurope_pmcdocument de 11 observations

8,3 %HBV DNA was detected in 14 of the 18 patients with positive or indeterminate HBsAg results, representing 8.3% of the total study population.

Camerounhépatite Bpublié 2009HIV MedicineOpenAlexdocument de 5 observations

25 %Ketoacidosis was the underlying cause of 25% of diabetic comas admitted to the endocrinology service of Yaounde Central Hospital between November 1999 and October 2002.

Camerouncoma · ketoacidosisobservé November 1999 to October 2002publié 2008Annals of tropical medicine and parasitologyeurope_pmcdocument de 12 observationsDOI 10.1179/136485908x252188

22,7 %Among patients with type 1 diabetes, the prevalence of diagnosed hypertension was 22.7% in wave 1 and 19.9% in wave 7.

Cameroundiabète de type 1 · hypertension artériellepublié 2021Diabetologiaeurope_pmcdocument de 14 observations

3,1 %Of those who had blood sugar tests, 3.1% had elevated blood sugar and were linked to care facilities.

Cameroundiabète (non précisé)publié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

45 %In 2010, 45% of 38 ART sites in Cameroon attained the target for ARV drug supply continuity (target = 100%).

CamerounVIH/sidaobservé 2010publié 2012PLoS ONEOpenAlexdocument de 5 observationsDOI 10.1371/journal.pone.0036777

7,8 %179 adults (7.8%) tested HIV-positive in the campaign.

CamerounVIH/sidaobservé 2011publié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

7 %Among 170 hunter-collected dried blood spots from 12 nonhuman primate species, 12 (7%) specimens were infected with simian T-cell lymphotropic virus (STLV).

Camerounsimian T-cell lymphotropic virus (STLV)publié 2009Emerging infectious diseasesOpenAlexdocument de 3 observationsDOI 10.3201/eid1502.080584

37 %Fatal events due to cardiovascular-related conditions were more frequent in the presence of metabolic syndrome both 1 year (37% vs. 9%) and 5 years after the first-ever-in-lifetime stroke (43% vs. 13%, p = 0.017).

CamerounAVC · maladies cardiovasculaires · syndrome métaboliquepublié 2013PloS oneeurope_pmcdocument de 6 observations

98 %The high seroprevalence of T gondii in Cameroon was 98% compared with Malawi (14%) and Tanzania (57%) within this cohort with suspected HIV-related CNS infection.

CamerounT gondiiHAL · Unilimdocument de 205 observations

40,1 %Une enquête réalisée par le Programme national de lutte contre le Paludisme en 2004 a montré que le paludisme représente 40,1 % de la morbidité chez la population en général au Cameroun.

Camerounpaludismeobservé 2004HAL · Unilimdocument de 98 observations

70 percent_of_GNI_per_capitaThe minimum estimated cost for the treatment of diabetes with nephropathy in the public sector is above 70% of the country's gross national income per capita.

Camerounnephropathy · type-2 diabetespublié 2015World journal of diabeteseurope_pmcdocument de 3 observations

3 018 per_100000Substance use disorders had an age-standardised prevalence of 3018 cases per 100,000 in males in 2017.

Camerounsubstance use disordersobservé 2017publié 2018Lancet (London, England)europe_pmcdocument de 14 observations

89 mmHgThe mean nighttime mean arterial pressure was 89 ± 9 mmHg in the diabetic group.

Cameroundiabète de type 1publié 2017World journal of diabeteseurope_pmcdocument de 9 observations

29 %29% of Cameroonian patients with diabetes presented at least one diabetes-associated antibody.

Cameroundiabète (non précisé)publié 2014Diabetes research and clinical practiceeurope_pmcdocument de 5 observationsDOI 10.1016/j.diabres.2013.11.013

23 %Among offspring of type 2 diabetic parents in Cameroon, 23% were glucose intolerant, including 4% with diabetes and 19% with impaired glucose tolerance.

Camerounglucose intolerancepublié 2000Diabetes careeurope_pmcdocument de 2 observationsDOI 10.2337/diacare.23.12.1761

The methanol extract of the aerial parts of Eriosema laurentii transactivated the estrogen receptor-α and displayed AhR agonistic activity but was neither androgenic nor progesteronic.

Camerounmenopausal health problemspublié 2013Journal of ethnopharmacologyeurope_pmcdocument de 9 observations

46,2 %Wasting of thigh muscles was present in 46.2% of Cameroonian Duchenne Muscular Dystrophy patients (6 out of 13).

CamerounDuchenne Muscular Dystrophypublié 2020Molecular genetics & genomic medicineeurope_pmcdocument de 11 observations

16,2 %Heavy legs were reported by 16.2% of participants with chronic venous disease.

Camerounchronic venous diseaseobservé 2020-2021publié 2024Phlebologyeurope_pmcdocument de 9 observations

85,7 %Flexion contractures were present in 85.7% of Cameroonian Duchenne Muscular Dystrophy patients on the ankle (12 out of 14).

CamerounDuchenne Muscular Dystrophypublié 2020Molecular genetics & genomic medicineeurope_pmcdocument de 11 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.